Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote SEK

Swedencare AB (publ) (0ABG.IL)

33.80
-3.45
(-9.26%)
At close: April 24 at 5:34:07 PM GMT+1
Loading Chart for 0ABG.IL
  • Previous Close 37.25
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 64.68
  • Volume 1,728
  • Avg. Volume 41,092
  • Market Cap (intraday) 6.263B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 102.42
  • EPS (TTM) 0.33
  • Earnings Date Jul 23, 2025
  • Forward Dividend & Yield 0.22 (0.63%)
  • Ex-Dividend Date May 2, 2023
  • 1y Target Est --

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. It offers products and solutions for the pets wellbeing under the Camon name; animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. The company also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, it offers ProDen PlaqueOff powder, a solution for pet oral problems; ProDen PlaqueOff dental bones; ProDen PlaqueOff dental bites, a pet dental product; and Rx Vitamins for Pets. The company distributes its products through veterinarians, pet stores, and online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.

www.swedencare.com

499

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0ABG.IL

View More

Performance Overview: 0ABG.IL

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

0ABG.IL
29.35%
OMX Stockholm 30 Index (^OMX)
3.39%

1-Year Return

0ABG.IL
40.18%
OMX Stockholm 30 Index (^OMX)
5.68%

3-Year Return

0ABG.IL
61.21%
OMX Stockholm 30 Index (^OMX)
14.51%

5-Year Return

0ABG.IL
61.21%
OMX Stockholm 30 Index (^OMX)
58.43%

Compare To: 0ABG.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0ABG.IL

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    5.93B

  • Enterprise Value

    7.21B

  • Trailing P/E

    60.08

  • Forward P/E

    25.19

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.33

  • Price/Book (mrq)

    0.74

  • Enterprise Value/Revenue

    2.84

  • Enterprise Value/EBITDA

    13.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.56%

  • Return on Assets (ttm)

    0.93%

  • Return on Equity (ttm)

    0.70%

  • Revenue (ttm)

    2.08B

  • Net Income Avi to Common (ttm)

    53.05M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    197.6M

  • Total Debt/Equity (mrq)

    23.48%

  • Levered Free Cash Flow (ttm)

    35.49M

Research Analysis: 0ABG.IL

View More

Company Insights: 0ABG.IL

Research Reports: 0ABG.IL

View More

People Also Watch